Adesis - About the company
Adesis is an acquired company based in New Castle (United States), founded in 2005. It operates as a CDMO accelerating success with innovative chemistry for biotech, pharma, and specialty chemicals. The company has 242 active competitors, including 22 funded and 33 that have exited. Its top competitors include companies like Sai Life Sciences, IRBM and NFIL.
Company Details
CDMO accelerating success with innovative chemistry for biotech, pharma, and specialty chemicals. They are a contract development and manufacturing organization providing organic chemistry services. Their business model includes early-stage discovery research, non-GMP scale-up and process development, and specialty manufacturing. They specialize in organic and organometallic synthesis, from milligrams to multi-kilogram quantities. They are known for expertise in heterocycles, deuteration and high purity monomers. They offer innovative, agile and integrated drug discovery collaboration to deliver high purity, quantity and speed. They are committed to delivering cost-effective, safe and scalable chemical processes. They have extensive chemistry, sourcing and manufacturing capabilities to safely and seamlessly transfer from discovery to manufacturing with high quality and speed.
- Website
- adesisinc.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2005
Location
New Castle, United States
Stage
Acquired
Ranked
35th among 242 active competitors
Employee Count
179 as on Sep 30, 2026
Similar Companies
Exit Details
Acquired by Universal Display Corporation (Jun 23, 2016)
Legal entities associated with Adesis
Adesis is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
ADESIS INC. CIN: 61746488 , United States, Active | Dec 31, 1999 | - | 165 (As on Dec 31, 2024) | - |
Adesis's acquisition details
Adesis got acquired by Universal Display Corporation on Jun 23, 2016 at an acquisition amount of $*****.
Click here to take a look at Adesis's acquisition in detail
Sign up to download Adesis' company profile
Adesis's funding and investors
Adesis has not raised any funding rounds yet.
Adesis' founders and board of directors
Founder? Claim ProfileAdesis' employee count trend
Adesis has 179 employees as of Sep 26. Here is Adesis's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Adesis's Competitors and alternates
Top competitors of Adesis include Sai Life Sciences, IRBM and NFIL. Here is the list of Top 10 competitors of Adesis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sai Life Sciences 1999, Hyderabad (India), Public | Provider of drug discovery, development, and manufacturing of complex small molecules | $108M | 67/100 | |
2nd | Integrated drug discovery and preclinical development service provider | - | 50/100 | ||
3rd | CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds | - | - | 50/100 | |
4th | Integrated drug discovery and preclinical development services | - | 50/100 | ||
5th | GL Chemtec International 2002, Oakville (Canada), Acquired | Discovery stage CRO specializing in custom synthesis of fine chemicals and intermediates | - | - | 49/100 |
6th | Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis | $71M | 49/100 | ||
7th | Alzheimer's Drug Discovery 1998, New York City (United States), Funding Raised | Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease | - | 47/100 | |
8th | Bioduro 2005, San Diego (United States), Acquired | Global CRDMO providing integrated drug discovery, development, and manufacturing services | - | 47/100 | |
9th | Wilmington Pharmatech 2003, Newark (United States), Acquired | Integrated CRO/CMO providing API, custom synthesis, and analytical services | - | - | 44/100 |
10th | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | - | 44/100 | ||
35th | Adesis 2005, New Castle (United States), Acquired | CDMO accelerating success with innovative chemistry for biotech, pharma, and specialty chemicals | - | - | 33/100 |
Looking for more details on Adesis's competitors? Click here to see the top ones
Adesis's Investments and acquisitions
Adesis has made no investments or acquisitions yet.
Reports related to Adesis
Here is the latest report on Adesis's sector:
News related to Adesis
•
Adesis Announces Expansion at Delaware’s DuPont Experimental StationBusiness Wire•Sep 08, 2021•Adesis
•
Adesis Announces Linda Choi MacDonald as New Chief Operating OfficerBusiness Wire•Aug 30, 2021•Adesis, Avanir
•
•
•
Adesis Announces Helen Stimson as Chief Operating OfficerCMOCRO•May 28, 2020•Adesis, Universal Display Corporation
•
Adesis, Inc. Commemorates State-of-the-Art Laboratory Expansion with Ribbon Cutting CeremonyBioSpace•Oct 22, 2018•Adesis
•
Adesis Announces Joanne Johnson as Vice President of Business DevelopmentBusiness Wire•Jan 04, 2018•Adesis
•
Adesis Grows Business and Expands Its Fundamental Chemistry Capabilities in DelawareBusiness Wire•Dec 11, 2017•Adesis
Are you a Founder ?
FAQs about Adesis
Explore our recently published companies
- Pro City Supply - Tampa based, 2005 founded, Unfunded company
- Avesdex Unity Bank - Cambridge based, 2026 founded, Unfunded company
- Finova - Kumasi based, 2025 founded, Unfunded company
- Convello - Valsad based, 1998 founded, Unfunded company
- Akshat Green - Patna based, 2025 founded, Unfunded company
- Xunoia - Hyderabad based, 2025 founded, Unfunded company
